US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apimeds Pharmaceutical U.S, Inc.

2.20

-0.0900-3.93%

Volume:29.33K

Turnover:68.28K

Market Cap:3.32M

PE:-0.06

High:2.47

Open:2.30

Low:2.18

Close:2.29

52wk High:59.70

52wk Low:2.17

Shares:1.51M

Float Shares:304.73K

Volume Ratio:0.90

T/O Rate:9.63%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-38.5450

EPS(LYR):-0.1759

ROE:-144.99%

ROA:-69.29%

PB:0.41

PE(LYR):-12.51

Loading ...

Overview Company News Filings

Business Combinations

Form 425 - Prospectuses and communications, business combinations

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Major Issues Report

Form 8-K - Current report

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans

Major Issues Report

Form 8-K - Current report

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Major Issues Report

Form 8-K - Current report

Correspondence

Form CORRESP - Correspondence

Correspondence

Form CORRESP - Correspondence

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Correspondence

Form CORRESP - Correspondence

Correspondence

Form CORRESP - Correspondence

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Major Issues Report

Form 8-K - Current report

Correspondence

Form CORRESP - Correspondence

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/APUS/filings?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","market":"US","secType":"STK","nameCN":"Apimeds Pharmaceutical  U.S, Inc.","latestPrice":2.2,"timestamp":1789065283246,"preClose":2.29,"halted":0,"volume":29332,"delay":0,"changeRate":-0.03930131004366806,"floatShares":304730,"shares":1509119,"eps":-38.545,"marketStatus":"Trading","change":-0.09,"latestTime":"09-10 14:34:53 EDT","open":2.3,"high":2.47,"low":2.18,"amount":68281.6753464,"amplitude":0.126638,"askPrice":2.28,"askSize":100,"bidPrice":2.15,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-38.545,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"listingDate":1746763200000,"exchange":"AMEX","adjPreClose":2.29,"preHourTrading":{"tag":"盘前","latestPrice":2.27,"preClose":2.29,"latestTime":"09:13 EDT","volume":253,"amount":588.682171,"timestamp":1789045999709,"change":-0.02,"changeRate":-0.008734,"amplitude":0.259258},"postHourTrading":{"tag":"盘后","latestPrice":2.29,"preClose":2.29,"latestTime":"19:29 EDT","volume":35,"amount":74.63,"timestamp":1788996587383,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.903575},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","floatShares":304730,"roa":"-69.29%","roe":"-144.99%","lyrEps":-0.175862,"volumeRatio":0.903575,"shares":1509119,"dividePrice":0,"high":2.47,"amplitude":0.126638,"preClose":2.29,"low":2.18,"week52Low":2.17,"pbRate":"0.41","week52High":59.7,"institutionHeld":0,"latestPrice":2.2,"committee":-0.960784,"eps":-38.545,"divideRate":0,"volume":29332,"delay":0,"ttmEps":-38.545,"open":2.3,"prevYearClose":16.4,"prevWeekClose":2.42,"prevMonthClose":3.88,"prevQuarterClose":9,"fiveDayClose":2.63,"twentyDayClose":4.66,"sixtyDayClose":13.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APUS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-24","symbol":"APUS","defaultRemindTime":1784899800000,"type":"split","dateTimestamp":1784865600000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APUS","date":"2025-12-01","current":-0.059411,"percent":0.642384,"low":-37.866629,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"high":-4.754876,"avg":-11.953693,"sd":7.073766,"marketCap":36470350},"quantilePoints":[{"date":"2025-02-21","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-02-28","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-03-05","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-05-09","current":-18.309826,"twenty":-34.716764,"median":-34.716764,"eighty":-33.299512,"marketCap":25450475},{"date":"2025-05-16","current":-14.148502,"twenty":-34.716764,"median":-34.008138,"eighty":-15.063993,"marketCap":19666276},{"date":"2025-05-23","current":-14.074662,"twenty":-34.716764,"median":-18.309826,"eighty":-14.306662,"marketCap":21054484},{"date":"2025-05-30","current":-13.387434,"twenty":-34.716764,"median":-15.063993,"eighty":-14.061031,"marketCap":20026450},{"date":"2025-06-06","current":-14.702962,"twenty":-34.716764,"median":-14.800251,"eighty":-13.996937,"marketCap":21994367},{"date":"2025-06-13","current":-14.314495,"twenty":-34.716764,"median":-14.564634,"eighty":-14.061031,"marketCap":21413253},{"date":"2025-06-20","current":-13.774354,"twenty":-33.866413,"median":-14.548195,"eighty":-14.0474,"marketCap":20605249},{"date":"2025-06-27","current":-13.296895,"twenty":-33.299512,"median":-14.356338,"eighty":-13.867215,"marketCap":19891011},{"date":"2025-07-03","current":-13.774354,"twenty":-27.303638,"median":-14.27266,"eighty":-13.727614,"marketCap":20605249},{"date":"2025-07-11","current":-14.006506,"twenty":-17.177946,"median":-14.161274,"eighty":-13.727614,"marketCap":20952529},{"date":"2025-07-18","current":-13.851738,"twenty":-15.354982,"median":-14.154888,"eighty":-13.727614,"marketCap":20721009},{"date":"2025-07-25","current":-16.173259,"twenty":-16.219689,"median":-14.161274,"eighty":-13.727614,"marketCap":24193804},{"date":"2025-08-01","current":-13.464818,"twenty":-16.219689,"median":-14.199966,"eighty":-13.727614,"marketCap":20142210},{"date":"2025-08-08","current":-12.14929,"twenty":-16.049445,"median":-14.148502,"eighty":-13.573156,"marketCap":18174293},{"date":"2025-08-15","current":-12.265366,"twenty":-15.710284,"median":-14.056061,"eighty":-13.418388,"marketCap":18347933},{"date":"2025-08-22","current":-7.697345,"twenty":-15.447843,"median":-14.006506,"eighty":-13.015991,"marketCap":28547481},{"date":"2025-08-29","current":-6.307075,"twenty":-15.306558,"median":-13.929122,"eighty":-12.721932,"marketCap":23391328},{"date":"2025-09-05","current":-6.307075,"twenty":-15.146611,"median":-13.929122,"eighty":-12.474303,"marketCap":23391328},{"date":"2025-09-12","current":-6.578348,"twenty":-15.038217,"median":-13.851738,"eighty":-12.234412,"marketCap":24397407},{"date":"2025-09-19","current":-6.205348,"twenty":-14.9276,"median":-13.774354,"eighty":-7.507455,"marketCap":23014048},{"date":"2025-09-26","current":-6.049367,"twenty":-14.889578,"median":-13.773581,"eighty":-6.849619,"marketCap":22435553},{"date":"2025-10-03","current":-5.832349,"twenty":-14.826776,"median":-13.69697,"eighty":-6.578348,"marketCap":21630690},{"date":"2025-10-10","current":-6.307075,"twenty":-14.675296,"median":-13.542202,"eighty":-6.472551,"marketCap":23391328},{"date":"2025-10-17","current":-6.239257,"twenty":-14.561346,"median":-13.50351,"eighty":-6.415584,"marketCap":23139808},{"date":"2025-10-24","current":-5.879822,"twenty":-14.548195,"median":-13.387434,"eighty":-6.358617,"marketCap":21806754},{"date":"2025-10-31","current":-6.917438,"twenty":-14.538909,"median":-13.039206,"eighty":-6.374893,"marketCap":25655005},{"date":"2025-11-07","current":-8.524725,"twenty":-14.481047,"median":-12.845746,"eighty":-6.381675,"marketCap":31616021},{"date":"2025-11-14","current":-9.460613,"twenty":-14.381444,"median":-12.652286,"eighty":-6.415584,"marketCap":35086992},{"date":"2025-11-21","current":-5.852155,"twenty":-14.312928,"median":-12.458826,"eighty":-6.415584,"marketCap":30182359},{"date":"2025-11-28","current":-7.071353,"twenty":-14.306662,"median":-12.304058,"eighty":-6.374893,"marketCap":36470350},{"date":"2025-12-01","current":-7.071353,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"marketCap":36470350}],"updateTime":1789032748397},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"APUS\",pageSize:20,pageCount:2,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"20479272","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025117176-APUS","pdf_url":"","pub_time":1764651600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 425 - Prospectuses and communications, business combinations","symbol":"APUS","title":"Form 425 - Prospectuses and communications, business combinations","titleType":"Business Combinations","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/0001213900-25-117176-index.htm","us_notice_code":"Form 425","us_title_en":"Form 425 - Prospectuses and communications, business combinations","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea0267807-8k425_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0267807-8k425_apimeds.htm","type":"425","id":"NTFILE9rQhvKYqYcAn6HNq","market":"us","size":99345},{"description":"AGREEMENT AND PLAN OF MERGER, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHA","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex2-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex2-1_apimeds.htm","type":"EX-2.1","id":"NTFILEAemMZkjRsuzW2XWn","market":"us","size":467002},{"description":"CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK, AS FILED WIT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex3-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex3-1_apimeds.htm","type":"EX-3.1","id":"NTFILEHFCxmwtv6dqY4VDu","market":"us","size":33204},{"description":"FORM OF NOTE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex4-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex4-1_apimeds.htm","type":"EX-4.1","id":"NTFILEH4MBk71gu2mRYMQ9","market":"us","size":254303},{"description":"WARRANT ISSUED TO E.F. HUTTON & CO. LLC, DATED DECEMBER 1, 2025","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex4-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex4-2_apimeds.htm","type":"EX-4.2","id":"NTFILE53LnuA1NnbVYp26s","market":"us","size":114309},{"description":"ACQUIROR SUPPORT AGREEMENT, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHARM","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex10-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILE87exrBV9W1UYxvTW","market":"us","size":76051},{"description":"SECURITIES PURCHASE AGREEMENT, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PH","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex10-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-2_apimeds.htm","type":"EX-10.2","id":"NTFILEAMUxGpUpesyggLMB","market":"us","size":355963},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex10-3_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-3_apimeds.htm","type":"EX-10.3","id":"NTFILE37ecYDuxBcWe5oBa","market":"us","size":172450},{"description":"FORM OF VOTING AGREEMENT","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex10-4_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-4_apimeds.htm","type":"EX-10.4","id":"NTFILEHQJ3r6NdRBDs4B4D","market":"us","size":28610},{"description":"PRESS RELEASE, DATED DECEMBER 1, 2025","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex99-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex99-1_apimeds.htm","type":"EX-99.1","id":"NTFILEGBTvjSG1PhuF2rCF","market":"us","size":22873}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"Business Combinations","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"Business Combinations","pubTime":"2025-12-02 13:00","pubTimestamp":1764651600,"title_zh":"Form 425 - Prospectuses and communications, business combinations","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20479258","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025117173-APUS","pdf_url":"","pub_time":1764651600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/0001213900-25-117173-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.01: Completion of Acquisition or Disposition of Assets;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AGREEMENT AND PLAN OF MERGER, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHA","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex2-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea026780701ex2-1_apimeds.htm","type":"EX-2.1","id":"NTFILEEG389FrDe8dzf4kg","market":"us","size":467002},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea0267807-8k425_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0267807-8k425_apimeds.htm","type":"8-K","id":"NTFILE3noYJLNUrgWgnwyZ","market":"us","size":107188},{"description":"CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK, AS FILED WIT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex3-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex3-1_apimeds.htm","type":"EX-3.1","id":"NTFILE6QXWFUMqW29aPJB9","market":"us","size":33204},{"description":"FORM OF NOTE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex4-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex4-1_apimeds.htm","type":"EX-4.1","id":"NTFILEEqKU5UR8S9U8BqGG","market":"us","size":254303},{"description":"WARRANT ISSUED TO E.F. HUTTON & CO. LLC, DATED DECEMBER 1, 2025","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex4-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex4-2_apimeds.htm","type":"EX-4.2","id":"NTFILEDWaWK18dhobHfwWp","market":"us","size":114309},{"description":"ACQUIROR SUPPORT AGREEMENT, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHARM","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex10-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILEEPSkr1v9J7eKNWoz","market":"us","size":76051},{"description":"SECURITIES PURCHASE AGREEMENT, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PH","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex10-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-2_apimeds.htm","type":"EX-10.2","id":"NTFILEGdKXYKyyZ4WQ3tDa","market":"us","size":355963},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex10-3_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-3_apimeds.htm","type":"EX-10.3","id":"NTFILE9EHk7mEQnWVZqiHQ","market":"us","size":172450},{"description":"FORM OF VOTING AGREEMENT","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex10-4_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-4_apimeds.htm","type":"EX-10.4","id":"NTFILE5wqMf8ndaqGUKhke","market":"us","size":28610},{"description":"PRESS RELEASE, DATED DECEMBER 1, 2025","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex99-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex99-1_apimeds.htm","type":"EX-99.1","id":"NTFILE85coqPEBeDXKCWTt","market":"us","size":22873}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-12-02 13:00","pubTimestamp":1764651600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.01: Completion of Acquisition or Disposition of Assets;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20426913","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025112184-APUS","pdf_url":"","pub_time":1763503060000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-25-112184-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT, DATED NOVEMBER 13, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025112184/ea026616601ex10-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea026616601ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILEGawRTNKw4kvbaYcC","market":"us","size":10061},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025112184/ea0266166-8k_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0266166-8k_apimeds.htm","type":"8-K","id":"NTFILEDfr1WG9zawSJPh81","market":"us","size":24427}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-11-19 05:57","pubTimestamp":1763503060,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20400506","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025109280-APUS","pdf_url":"","pub_time":1762923600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"APUS","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/0001213900-25-109280-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea0264386-10q_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0264386-10q_apimeds.htm","type":"10-Q","id":"NTFILEHyqe94raUy3Fo4nY","market":"us","size":576092},{"description":"WARRANT ISSUED TO MURDOCK CAPITAL PARTNERS CORP., DATED AUGUST 5, 2025","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex4-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex4-1_apimeds.htm","type":"EX-4.1","id":"NTFILEB9qZxrxBsEfqCwUX","market":"us","size":63202},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex31-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex31-1_apimeds.htm","type":"EX-31.1","id":"NTFILEDgi8v28Pu5EBXnn4","market":"us","size":15933},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex31-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex31-2_apimeds.htm","type":"EX-31.2","id":"NTFILEHoju1QdxYFKxjXTD","market":"us","size":10335},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex32-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex32-1_apimeds.htm","type":"EX-32.1","id":"NTFILE62f9Ly5MMJmENwKq","market":"us","size":3473},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex32-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex32-2_apimeds.htm","type":"EX-32.2","id":"NTFILE6NrMmj5jZN9ZfCk7","market":"us","size":3619}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2025-11-12 13:00","pubTimestamp":1762923600,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20273049","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025099553-APUS","pdf_url":"","pub_time":1760587200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/0001213900-25-099553-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FIRST AMENDMENT TO BYLAWS DATED OCTOBER 15, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/ea026154301ex3-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea026154301ex3-1_apimeds.htm","type":"EX-3.1","id":"NTFILEjwRyGFcMT7FBfCmZ","market":"us","size":2276},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/ea0261543-8k_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0261543-8k_apimeds.htm","type":"8-K","id":"NTFILEFjqKdffHFirbA9gJ","market":"us","size":23620}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-10-16 12:00","pubTimestamp":1760587200,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20010168","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025078507-APUS","pdf_url":"","pub_time":1755576000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"APUS","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/0001213900-25-078507-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea0251232-10q_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0251232-10q_apimeds.htm","type":"10-Q","id":"NTFILE2XrgMFFKD7rRNHHL","market":"us","size":547565},{"description":"AMENDMENT TO MAY 2024 PROMISSORY NOTE BY AND BETWEEN APIMEDS PHARMACEUTICALS US,","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex10-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILE9cJyFDVkP5trf7gP","market":"us","size":5457},{"description":"AMENDMENT TO AUGUST 2024 PROMISSORY NOTE BY AND BETWEEN APIMEDS PHARMACEUTICALS","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex10-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex10-2_apimeds.htm","type":"EX-10.2","id":"NTFILE72chVnRndzh9Zb7k","market":"us","size":6143},{"description":"AMENDMENT TO MARCH 2025 PROMISSORY NOTE BY AND BETWEEN APIMEDS PHARMACEUTICALS U","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex10-3_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex10-3_apimeds.htm","type":"EX-10.3","id":"NTFILEAc9Lfp16GVtTq5Y9","market":"us","size":6120},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex31-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex31-1_apimeds.htm","type":"EX-31.1","id":"NTFILE7DCEq8fcBhh8gJgP","market":"us","size":9313},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex31-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex31-2_apimeds.htm","type":"EX-31.2","id":"NTFILE2vD74iKgKvB1MTTo","market":"us","size":9315},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex32-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex32-1_apimeds.htm","type":"EX-32.1","id":"NTFILEH5X43EKFuZoiruKx","market":"us","size":3231},{"description":"CERTIFICATION","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex32-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex32-2_apimeds.htm","type":"EX-32.2","id":"NTFILECY2mG11YmP9kowKU","market":"us","size":3241}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2025-08-19 12:00","pubTimestamp":1755576000,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19882994","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025064446-APUS","pdf_url":"","pub_time":1752638400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025064446/0001213900-25-064446-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE DATED JULY 15, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025064446/ea024916001ex99-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea024916001ex99-1_apimeds.htm","type":"EX-99.1","id":"NTFILEmN3fT5MbimsCQjYQ","market":"us","size":12075},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025064446/ea0249160-8k_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0249160-8k_apimeds.htm","type":"8-K","id":"NTFILE3bvxq9nAhmqS5h4s","market":"us","size":26453}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-07-16 12:00","pubTimestamp":1752638400,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19739711","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025051567-APUS","pdf_url":"","pub_time":1749096000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025051567/0001213900-25-051567-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025051567/ea024484201-8k_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea024484201-8k_apimeds.htm","type":"8-K","id":"NTFILE8odsqxzEQdrP2LhW","market":"us","size":25286}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-06-05 12:00","pubTimestamp":1749096000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19690639","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025047373-APUS","pdf_url":"","pub_time":1747972800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 - Securities to be offered to employees in employee benefit plans","symbol":"APUS","title":"Form S-8 - Securities to be offered to employees in employee benefit plans","titleType":"Employee Stock Ownership","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/0001213900-25-047373-index.htm","us_notice_code":"Form S-8","us_title_en":"Form S-8 - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ea0242959-s8_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0242959-s8_apimeds.htm","type":"S-8","id":"NTFILE52LggoZe9FSSHnne","market":"us","size":53045},{"description":"OPINION OF NELSON MULLINS RILEY & SCARBOROUGH LLP AS TO THE LEGALITY OF THE SECU","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ea024295901ex5-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024295901ex5-1_apimeds.htm","type":"EX-5.1","id":"NTFILEGbtC3PY5TFp9DAnt","market":"us","size":12212},{"description":"CONSENT OF KREIT & CHIU CPA LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ea024295901ex23-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024295901ex23-1_apimeds.htm","type":"EX-23.1","id":"NTFILEASjHarz4gRW42xs2","market":"us","size":2030},{"description":"FILING FEE TABLE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ea024295901ex-fee_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024295901ex-fee_apimeds.htm","type":"EX-FILING FEES","id":"NTFILE6zTmXzxE3Fdy9iq7","market":"us","size":10134},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE4FaMqqBxBSTTBAuz","market":"us","size":2814}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Employee Stock Ownership","pubTime":"2025-05-23 12:00","pubTimestamp":1747972800,"title_zh":"Form S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19671159","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025045643-APUS","pdf_url":"","pub_time":1747713600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/0001213900-25-045643-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM OF AMENDMENT TO PROMISSORY NOTE","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/ea024276701ex10-1_apimed.htm","primary":true,"translateUrl":"","linkName":"ea024276701ex10-1_apimed.htm","type":"EX-10.1","id":"NTFILEGXcXLPzK3PfgAAB9","market":"us","size":5177},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/ea024276701-8k_apimed.htm","primary":false,"translateUrl":"","linkName":"ea024276701-8k_apimed.htm","type":"8-K","id":"NTFILECf2xaduGGxzYw5xW","market":"us","size":25001}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-05-20 12:00","pubTimestamp":1747713600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19671158","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025045588-APUS","pdf_url":"","pub_time":1747713600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"APUS","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/0001213900-25-045588-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea0241519-10q_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0241519-10q_apimeds.htm","type":"10-Q","id":"NTFILEEEU2rwaciswP2wSB","market":"us","size":354005},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea024151901ex31-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024151901ex31-1_apimeds.htm","type":"EX-31.1","id":"NTFILE6vfDEW92ghBCzDGe","market":"us","size":10274},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea024151901ex31-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024151901ex31-2_apimeds.htm","type":"EX-31.2","id":"NTFILE5P147gtvb7K1qznN","market":"us","size":10279},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea024151901ex32-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024151901ex32-1_apimeds.htm","type":"EX-32.1","id":"NTFILE4kZhUNEJuEFWosf4","market":"us","size":3789},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea024151901ex32-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024151901ex32-2_apimeds.htm","type":"EX-32.2","id":"NTFILE5FFDFRBmgG3oeLoF","market":"us","size":3801}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2025-05-20 12:00","pubTimestamp":1747713600,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19631585","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025042122-APUS","pdf_url":"","pub_time":1747022400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/0001213900-25-042122-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"UNDERWRITING AGREEMENT, DATED MAY 8, 2025, BETWEEN THE COMPANY AND D. BORAL CAPI","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex1-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea024171101ex1-1_apimeds.htm","type":"EX-1.1","id":"NTFILEEuWUTJ5frmpR5i91","market":"us","size":471273},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea0241711-8k_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0241711-8k_apimeds.htm","type":"8-K","id":"NTFILE3PRgPNmrXnQw9kdc","market":"us","size":28114},{"description":"REPRESENTATIVE'S WARRANTS, DATED MAY 12, 2025, TO JOSEPH T. RALLO","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex4-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024171101ex4-1_apimeds.htm","type":"EX-4.1","id":"NTFILED2mbjCPZrUmANpp2","market":"us","size":118449},{"description":"FORM OF INDEMNIFICATION AGREEMENT","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex10-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024171101ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILEBJGf68uce4xmdQah","market":"us","size":99414},{"description":"PRESS RELEASE, DATED MAY 8, 2025","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex99-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024171101ex99-1_apimeds.htm","type":"EX-99.1","id":"NTFILE93jEdW79RkCDHFR4","market":"us","size":13261},{"description":"PRESS RELEASE, DATED MAY 12, 2025","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex99-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024171101ex99-2_apimeds.htm","type":"EX-99.2","id":"NTFILEDjSHWbmn3WfmsWgi","market":"us","size":10936}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-05-12 12:00","pubTimestamp":1747022400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19928808","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025039670-APUS","pdf_url":"","pub_time":1746474573000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"APUS","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-25-039670-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025039670/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE88uf2DtjWMwsCasn","market":"us","size":5769}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-05-06 03:49","pubTimestamp":1746474573,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19928885","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025039664-APUS","pdf_url":"","pub_time":1746474474000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"APUS","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-25-039664-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025039664/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE8Qg1ZfdBwPitc8qR","market":"us","size":6205}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-05-06 03:47","pubTimestamp":1746474474,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19594720","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025038644-APUS","pdf_url":"","pub_time":1746158400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","symbol":"APUS","title":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","titleType":"[Rev.]Annual Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038644/0001213900-25-038644-index.htm","us_notice_code":"Form 10-K/A","us_title_en":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO FORM 10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038644/ea0240523-10ka1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0240523-10ka1_apimeds.htm","type":"10-K/A","id":"NTFILEDRwCD4wiaJrBbEoc","market":"us","size":72679},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038644/ea024052301ex31-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024052301ex31-1_apimeds.htm","type":"EX-31.1","id":"NTFILE7ckuwFxfaJAQTkKV","market":"us","size":9548},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038644/ea024052301ex31-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024052301ex31-2_apimeds.htm","type":"EX-31.2","id":"NTFILE8XWnmRSrLZE8AKLz","market":"us","size":9560}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"[Rev.]Annual Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"[Rev.]Annual Report","pubTime":"2025-05-02 12:00","pubTimestamp":1746158400,"title_zh":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19923543","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025038649-APUS","pdf_url":"","pub_time":1746148327000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"APUS","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-25-038649-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038649/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE2uzg2NCiYs1zWBqr","market":"us","size":11363},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038649/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE4hzhNsyUNkKkj2kJ","market":"us","size":2769}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-05-02 09:12","pubTimestamp":1746148327,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19928787","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025038451-APUS","pdf_url":"","pub_time":1746130291000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"APUS","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-25-038451-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038451/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEA6fMebXj3zne8p8y","market":"us","size":12949},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038451/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILECLtkbKuPJcQhymrR","market":"us","size":2769}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-05-02 04:11","pubTimestamp":1746130291,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19397323","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025032206-APUS","pdf_url":"","pub_time":1744689600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"APUS","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"Annual Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/0001213900-25-032206-index.htm","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/ea0237283-10k_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0237283-10k_apimeds.htm","type":"10-K","id":"NTFILEG4MBY6cLP8EqftgP","market":"us","size":827741},{"description":"CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATIO","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/ea023728301ex3-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea023728301ex3-2_apimeds.htm","type":"EX-3.2","id":"NTFILEAznhmqzwbyc46nyA","market":"us","size":15080},{"description":"AMENDED AND RESTATED BYLAWS OF APIMEDS PHARMACEUTICALS US, INC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/ea023728301ex3-3_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea023728301ex3-3_apimeds.htm","type":"EX-3.3","id":"NTFILE5GMneDPi8aj7K2ep","market":"us","size":141662},{"description":"DESCRIPTION OF SECURITIES","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/ea023728301ex4-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea023728301ex4-1_apimeds.htm","type":"EX-4.1","id":"NTFILE3AzSNPtcKkcuuiDU","market":"us","size":27848},{"description":"MARCH 2025 PROMISSORY NOTE BY AND BETWEEN APIMEDS PHARMACEUTICALS US, INC. AND A","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/ea023728301ex10-26_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea023728301ex10-26_apimeds.htm","type":"EX-10.26","id":"NTFILE2NNyT1tu7pJTM7Qr","market":"us","size":19120},{"description":"INSIDER TRADING POLICY","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/ea023728301ex19-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea023728301ex19-1_apimeds.htm","type":"EX-19.1","id":"NTFILEEdyZbpZ3KaZ4TfjE","market":"us","size":63303},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/ea023728301ex31-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea023728301ex31-1_apimeds.htm","type":"EX-31.1","id":"NTFILEFEvZfbjB5Zdc5ptC","market":"us","size":9886},{"description":"CERTIFICATION","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/ea023728301ex31-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea023728301ex31-2_apimeds.htm","type":"EX-31.2","id":"NTFILE3jvUKQ9GsAv6PMks","market":"us","size":10106},{"description":"CERTIFICATION","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/ea023728301ex32-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea023728301ex32-1_apimeds.htm","type":"EX-32.1","id":"NTFILEHtsDDVhRzyZp5dvy","market":"us","size":4640},{"description":"CERTIFICATION","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/ea023728301ex32-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea023728301ex32-2_apimeds.htm","type":"EX-32.2","id":"NTFILEBiD45KeQHJ4MaBp7","market":"us","size":4610},{"description":"EXECUTIVE COMPENSATION RECOVERY POLICY","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/ea023728301ex97-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea023728301ex97-1_apimeds.htm","type":"EX-97.1","id":"NTFILE24aPUtEUgpT9rJJc","market":"us","size":17767},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEC77Drwpn7iwpXUH1","market":"us","size":38347},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/image_002.jpg","primary":false,"translateUrl":"","linkName":"image_002.jpg","type":"GRAPHIC","id":"NTFILE6h9oHeEc9FbmH5UW","market":"us","size":12799},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/ex3-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex3-2_001.jpg","type":"GRAPHIC","id":"NTFILE6LdJYgbbu9LYxnoE","market":"us","size":4988},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032206/ex3-2_002.jpg","primary":false,"translateUrl":"","linkName":"ex3-2_002.jpg","type":"GRAPHIC","id":"NTFILEBkVPgHMVFVwG63jV","market":"us","size":5075}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Annual Report","pubTime":"2025-04-15 12:00","pubTimestamp":1744689600,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19397168","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025032176-APUS","pdf_url":"","pub_time":1744689600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032176/0001213900-25-032176-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDED AND RESTATED BYLAWS OF APIMEDS PHARMACEUTICALS US, INC.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032176/ea023844301ex3-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea023844301ex3-1_apimeds.htm","type":"EX-3.1","id":"NTFILEEzdeWD6ywr58vEkF","market":"us","size":141934},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025032176/ea0238443-8k_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0238443-8k_apimeds.htm","type":"8-K","id":"NTFILE9iGFyZwA9LYreejc","market":"us","size":23529}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-04-15 12:00","pubTimestamp":1744689600,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19233365","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025011564-APUS","pdf_url":"","pub_time":1739200543000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"APUS","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-25-011564-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025011564/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEG1KcRvSB5DEH2QPw","market":"us","size":10421},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025011564/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILE4s9dyPC1izgQhJG8","market":"us","size":2767}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-02-10 23:15","pubTimestamp":1739200543,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":52,"code":"91000000","status":"200"}]}}